发明名称 Treatment of Operable High-Grade Glioma With Sitimagene Ceradenovec Gene Therapy and Ganciclovir
摘要 Gene therapy with genes for prodrug converting enzymes adds to local control of glioblastoma achieved by surgery. There appears to be a pronounced local reaction which is in part inflammatory and has a measurable immunological component. Considering the widely proven fact that during the weekslong gap-phase between surgery and completion of radiation or chemoradiation tumour growth from the infiltrative zone may continue unhampered, a treatment such as SIT will cover that time period.
申请公布号 US2016058888(A1) 申请公布日期 2016.03.03
申请号 US201414787887 申请日期 2014.05.08
申请人 FINVECTOR VISION THERAPIES LIMITED ;PHARMACEUTICAL PATENT ATTOENEYS, LLC. 发明人 Yla-Herttuala Seppo
分类号 A61K48/00;A61K31/522;A61K38/45;A61K31/495 主分类号 A61K48/00
代理机构 代理人
主权项 1. In a method of treating glioblastoma in a human by surgical resection and temozolomide, an improvement comprising: b. administering locally about the surgical resection site after surgical resection, about 1×1012 particles of replication-deficient adenovirus serotype 5 with E1 and partial E3 deletions, and containing the cDNA for HSV-tk which is able to phosphorylate ganciclovir, then c. administering gancyclovir 5 mg/kg i.v., twice daily.
地址 Chinnor, Oxfordshire GB